NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its ...

A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...

A team led by researchers at the University of Toronto has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of ...

In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...

Scientists at The Scripps Research Institute (TSRI) have found a new approach to the "reprogramming" of ordinary adult cells into stem cells. In a study published today in an Advance Online paper in ...

Years before he conducted the research that would earn him a Nobel Prize in Physiology and Medicine, Shinya Yamanaka, MD, ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. A woman ...

A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...